CNBX Pharmaceuticals Inc. (CNBX) Gross Margin (2016 - 2024)

CNBX Pharmaceuticals' (CNBX) quarterly Gross Margin came in at 84.69% in Q1 2024, down 15.31% on a QoQ basis from 100.0% in Q4 2018.

CNBX Pharmaceuticals Inc. (CNBX) Gross Margin (2016 - 2024) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 4 years of Gross Margin data on file, last reported at 84.69% in Q1 2024.

Quarterly Gross Margin changed N/A year-over-year to 84.69% in Q1 2024, while the trailing twelve-month figure through Feb 2024 was 7.34% (down 1601.0% YoY) and the FY2024 annual result came in at 100.0%, up 30.0% from the prior year.
Gross Margin declined to 84.69% in Q1 2024, from 100.0% in the prior quarter.
In the past five years, Gross Margin ranged from a high of 84.69% in Q1 2024 to a low of 84.69% in Q1 2024.

Download Data